Improvement of physicochemical properties of N-4472 part I formulation design by using self-micro emulsifying system

被引:44
作者
Itoh, K
Tozuka, Y
Oguchi, T
Yamamoto, K
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Inage Ku, Chiba 2638522, Japan
[2] Nisshin Seifun Grp Inc, Chiyoda Ku, Tokyo 1018441, Japan
关键词
optimized formulation; microemulsions; self-emulsifying systems; solubility enhancement; N-4472;
D O I
10.1016/S0378-5173(02)00085-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The optimization of oral dosage form formulation has been developed for N-4472, N-[2-(3,5-di-tert-butyl-4-hydroxyphenethyl)-4,6-difluorophenyl]-N'-[4-(N-benzylpiperidyl)] urea, which was a poorly water-soluble drug having a lipid-lowering effect. Formulations that contained various surfactants and water-soluble polymers were prepared and the solubility of N-4472 was evaluated in JP XIV first fluid (pH 1.2), JP XIV second fluid (pH 6.8), and distilled water. The highest solubility of N-4472 was achieved when L-ascorbic acid (VC), Gelucire(R) 44/14, and HCO-60(R) were used as additives. It was confirmed that this formulation could create microemulsion droplets with a mean droplet size of approximately 20 nm and a sharp droplet distribution pattern in JP XIV first fluid, JP XIV second fluid, and distilled water. When JP XIV second fluid was used as a dissolution medium, however, an eventual decrease of solubility was observed, that is, the fluid became white and cloudy as time passed. It was found that the addition of sodium dodecyl sulfate (SDS) was effective to prevent the lowering of solubility, and that a weight ratio of 1.0/1.5/11.4/4.9/3.8 for N-4472/VC/Gelucire(R) 44/14/HCO-60(R)/SDS was optimum for the self-microemulsifying formulation. It was assumed that electrostatic repulsion of microemulsion droplets and an increase of the cloud point by the addition of SDS were responsible for the successful formation of a stable microemulsion. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:153 / 160
页数:8
相关论文
共 17 条
[1]   Studies on cloud point of agrochemical microemulsions [J].
Chen, FL ;
Wang, Y ;
Zheng, FN ;
Wu, YT ;
Liang, WP .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2000, 175 (1-2) :257-262
[2]   Formulation and physical characterization of water-in-oil microemulsions containing long- versus medium-chain glycerides [J].
Constantinides, PP ;
Scalart, JP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 158 (01) :57-68
[3]   LIPID MICROEMULSIONS FOR IMPROVING DRUG DISSOLUTION AND ORAL ABSORPTION - PHYSICAL AND BIOPHARMACEUTICAL ASPECTS [J].
CONSTANTINIDES, PP .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1561-1572
[4]   Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 year [J].
Cooney, GF ;
Jeevanandam, V ;
Choudhury, S ;
Feutren, G ;
Mueller, EA ;
Eisen, HJ .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) :1892-1894
[5]   Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor [J].
Hauss, DJ ;
Fogal, SE ;
Ficorilli, JV ;
Price, CA ;
Roy, T ;
Jayara, AA ;
Keirns, JJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (02) :164-169
[6]  
ITOH K, 2001, UNPUB CHEM PHARM B
[7]   Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine [J].
Khoo, SM ;
Humberstone, AJ ;
Porter, CJH ;
Edwards, GA ;
Charman, WN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 167 (1-2) :155-164
[8]   The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment [J].
Khoo, SM ;
Porter, CJH ;
Charman, WN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 205 (1-2) :65-78
[9]   Pinning of phase separation of aqueous solution of hydroxypropylmethylcellulose by gelation [J].
Kita, R ;
Kaku, T ;
Kubota, K ;
Dobashi, T .
PHYSICS LETTERS A, 1999, 259 (3-4) :302-307
[10]   Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10:: formulation development and bioavailability assessment [J].
Kommuru, TR ;
Gurley, B ;
Khan, MA ;
Reddy, IK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (02) :233-246